Medicinal Chemistry Strategies Against Antimicrobial Resistance: From Target-Based Design To Resistance-Breaking Agents

Antimicrobial resistance (AMR) jeopardizes the effectiveness of nearly all principal antibiotic classes, while the development of new drugs is sparse and primarily consists of derivatives that bacteria are already capable of resisting. We emphasize the significance of medicinal chemistry as the field most adept at transforming resistance biology into compounds that can overcome it. Initially, we elucidate the molecular mechanisms underlying resistance such as target modification and protection, enzymatic inactivation, diminished permeability and efflux, biofilm tolerance, persistence and horizontal gene transfer and correlate each with a logical design strategy. Subsequently target-oriented and fragment-oriented design, scaffold enhancement of recognized antibiotic classes, beta-lactamase inhibitors, efflux pump inhibitors and adjuvants as well as anti-virulence and anti-biofilm chemistry, novel modalities such as antimicrobial peptides, macrocycles, degraders, nucleic-acid strategies and heterocyclic chemistry was also studied. Mainly emphasized on computational and AI-facilitated discovery, encompassing explainable deep learning, generative design and resistance-mutation forecasting, alongside the practicalities of hit-to-lead optimization, pharmacokinetics/pharmacodynamics, resistance-development assays, and the clinical pipeline that includes recent endorsements of first-in-class agents. Finally scientific, translational and economic obstacles that continue to impede advancement, particularly Gram-negative permeability, swift resistance emergence, market failure suggest a cohesive AI medicinal chemistry microbiology framework in which resistance profiling is incorporated into every design cycle rather than treated as an afterthought. Keywords: antimicrobial resistance; medicinal chemistry; resistance-breaking antibiotics; structure–activity relationships; Gram-negative permeability; β-lactamase inhibitors; heterocycles; artificial intelligence; hit-to-lead optimization; antibacterial pipeline

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24363435
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Medicinal Chemistry Strategies Against Antimicrobial Resistance: From Target-Based Design To Resistance-Breaking Agents

Komal G. Sangu, Dnyaneshwari B. Sapkal, Sheetal V. Wagh, Dhanashree R. Patil
Zenodo (CERN European Organization for Nuclear Research)
Antibiotic Resistance in Bacteria
article

Medicinal Chemistry Strategies Against Antimicrobial Resistance: From Target-Based Design To Resistance-Breaking Agents

Komal G. Sangu, Dnyaneshwari B. Sapkal, Sheetal V. Wagh, Dhanashree R. Patil
article en

Abstract

Antimicrobial resistance (AMR) jeopardizes the effectiveness of nearly all principal antibiotic classes, while the development of new drugs is sparse and primarily consists of derivatives that bacteria are already capable of resisting. We emphasize the significance of medicinal chemistry as the field most adept at transforming resistance biology into compounds that can overcome it. Initially, we elucidate the molecular mechanisms underlying resistance such as target modification and protection, enzymatic inactivation, diminished permeability and efflux, biofilm tolerance, persistence and horizontal gene transfer and correlate each with a logical design strategy. Subsequently target-oriented and fragment-oriented design, scaffold enhancement of recognized antibiotic classes, beta-lactamase inhibitors, efflux pump inhibitors and adjuvants as well as anti-virulence and anti-biofilm chemistry, novel modalities such as antimicrobial peptides, macrocycles, degraders, nucleic-acid strategies and heterocyclic chemistry was also studied. Mainly emphasized on computational and AI-facilitated discovery, encompassing explainable deep learning, generative design and resistance-mutation forecasting, alongside the practicalities of hit-to-lead optimization, pharmacokinetics/pharmacodynamics, resistance-development assays, and the clinical pipeline that includes recent endorsements of first-in-class agents. Finally scientific, translational and economic obstacles that continue to impede advancement, particularly Gram-negative permeability, swift resistance emergence, market failure suggest a cohesive AI medicinal chemistry microbiology framework in which resistance profiling is incorporated into every design cycle rather than treated as an afterthought. Keywords: antimicrobial resistance; medicinal chemistry; resistance-breaking antibiotics; structure–activity relationships; Gram-negative permeability; β-lactamase inhibitors; heterocycles; artificial intelligence; hit-to-lead optimization; antibacterial pipeline

Zenodo (CERN European Organization for Nuclear Research)
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon